Patent · US Active

Recombinant vector containing infectious human cytomegalovirus genome with preserved wild-type characteristics of clinical isolates

US7700350B2 · kind B2 · utility

4Cited by
0References
2Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJul 13, 2005
Grant dateApr 20, 2010
Priority date
Expiry dateDec 8, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/16161
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A recombinant vector containing infectious genome of human cytomegalovirus (HCMV) and being useful for the production of reconstituted HCMV virus retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells and to induce microfusion is characterized in that it is obtainable by inserting DNA from a clinical isolate of HCMV virus into a bacterial cloning vehicle. Such vector can be used e.g., for production of reconstituted HCMV virus retaining the phenotypic characteristics of a parental clinical isolate and for studying genes and functions of genes of HCMV virus. A further aspect are mutant viruses and inter alia their use for studying aspects of infectivity of HCMV virus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.